The effect of radioiodine therapy on blood cell count in patients with differentiated thyroid cancer
CONCLUSION: These results suggest an association between RAI dose and blood cell count abnormalities, characterized by mild lymphopenia, and indicate that the risk of mild lymphopenia persists over time. Careful consideration should be given when planning high-dose RAI for patients at a high risk of blood cell count abnormalities, such as males with metastatic disease and of advanced age.PMID:37603221 | DOI:10.1007/s42000-023-00479-x
Source: Hormones - Category: Endocrinology Authors: Ahmet Numan Demir Zehra Kara Cem Sulu Serhat Uysal Guldana Zulfaliyeva Oznur Aydin Atar Nahida Valikhanova Tulin Ozturk Hande Mefkure Ozkaya Taner Damci Mustafa Sait Gonen Source Type: research
More News: Cancer | Cancer & Oncology | Endocrinology | Hormones | Radioiodine Therapy | Study | Thyroid | Thyroid Cancer